You searched for "otological"

1013 results found

From the editor May/June 2023

Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTw: @Voicedoctor_uk The management of swallowing disorders is often seen as a ‘Cinderella’ field, so it is a real pleasure to be able...

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...

Are we making progress on tinnitus?

One of the aspects of tinnitus that drew me into it becoming a major theme of my clinical and research work was how little work had been done when I began to see patients in the mid 1980s. This struck...

ManCAD Research CAPers Conference

ManCAD's upcoming inaugural research conference has been playfully named ‘Research CAPers’ – as in Research Clinical Auditory Papers. This year’s conference highlighted the scientific accomplishments of Professor Dave Moore – who is retiring later this year from his various academic roles.

In conversation with Ray Clarke: Scott-Brown – The Editors’ view…

Ray Clarke. How did you get involved in the forthcoming Scott-Brown ? How does one become editor of a textbook? Editors are approached and appointed by the publishers, but of course publishers will take advice and soundings from within the...

Salivary duct clipping for drooling

Drooling can be a challenging problem to manage in paediatric ENT. The variety of medical and surgical treatments suggests that there is no gold standard treatment. Nicola Stobbs and Ravi Thevasagayam describe an approach to ligating the salivary ducts. Drooling...

Thyroid ultrasound elastography: does nodule stiffness predict malignancy?

Approximately 50% of the general population has a thyroid nodule while 5-15% of these are malignant [1]. A major challenge, therefore, is how to detect the malignant nodules for appropriate, timely treatment and avoid unnecessary, costly investigations for the remainder....

Plasticity with cochlear implants: individual factors in the outcomes

Andrej Kral gives us an overview of neuronal plasticity in congenital hearing loss, and discusses why it is core to our clinical interventions in hearing loss and rehabilitation. The brain is born immature and undergoes extensive shaping during early development....

Taking life by the throat

Patients suffering with problems with their voice, airway and/or swallowing can find their symptoms immensely distressing, and their care places a huge burden on healthcare systems. We hear from a world-leading laryngologist on current and future directions. Field of interest...

Neurological idiopathic disease: a shared journey for NASA and medicine

Whilst Southampton can’t really be described as an extreme environment, experiments carried out in the city have certainly been taken out of this world. Robert Marchbanks discusses one of the associations between Southampton, The International Space Station and tympanic membrane...

JAMA Network Reader

Accessing content from The Journal of the American Medical Association (JAMA) and its nine specialty journals (including JAMA Otolaryngology – Head & Neck Surgery) has now become a bit easier, thanks to an app designed for viewing JAMA articles on...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...